SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX)
CUSIP: 85205L107
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, par value $.0001 per share
- Shares outstanding
- 75,607,738
- Total 13F shares
- 73,697,303
- Share change
- -7,335,154
- Total reported value
- $3,254,809,380
- Put/Call ratio
- 43%
- Price per share
- $44.13
- Number of holders
- 304
- Value change
- -$236,161,841
- Number of buys
- 193
- Number of sells
- 108
Quarterly Holders Quick Answers
What is CUSIP 85205L107?
CUSIP 85205L107 identifies SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 85205L107:
Top shareholders of SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
15%
|
11,157,960
|
$403,137,095 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13D/G
13F
|
The Vanguard Group · Company |
9.6%
|
7,158,871
|
$331,026,195 | $0 | 31 Dec 2024 | |
| Stephen P. Squinto |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
6,333,277
mixed-class rows
|
$262,384,838 | — | 19 May 2022 | |
| ORBIMED ADVISORS LLC |
3/4/5
13F
|
10%+ Owner · Company |
1.7%
from 13F
|
5,599,842
|
$232,561,438 | — | 12 Sep 2022 | |
| BlackRock, Inc. |
13F
|
Company |
7.9%
|
5,960,359
|
$215,347,771 | — | 31 Dec 2024 | |
| Bain Capital Life Sciences Investors, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,832,413
|
$200,690,112 | — | 10 Aug 2021 | |
| Deep Track Capital, LP |
13D/G
13F
|
Company |
4.6%
|
3,460,756
|
$160,025,357 | $0 | 31 Dec 2024 | |
| Jeffrey Lawrence Schwartz |
3/4/5
|
Director |
—
mixed-class rows
|
3,105,653
mixed-class rows
|
$128,405,735 | — | 24 May 2023 | |
| Boxer Capital Management, LLC |
13F
|
Company |
4.5%
|
3,421,541
|
$123,620,276 | — | 31 Dec 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
4.3%
|
3,274,786
|
$118,319,000 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
4%
|
3,000,986
|
$108,425,624 | — | 31 Dec 2024 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
3.8%
|
2,891,852
|
$104,482,613 | — | 31 Dec 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
3.2%
|
2,391,412
|
$86,401,716 | — | 31 Dec 2024 | |
| Capital International Investors |
13F
|
Company |
3.1%
|
2,361,746
|
$85,329,883 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
2.6%
|
1,997,276
|
$72,161,591 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
1,670,208
|
$60,359,771 | — | 31 Dec 2024 | |
| EcoR1 Capital, LLC |
13F
|
Company |
2.1%
|
1,560,000
|
$56,362,800 | — | 31 Dec 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
2%
|
1,500,000
|
$54,195,000 | — | 31 Dec 2024 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
2%
|
1,499,134
|
$54,163,711 | — | 31 Dec 2024 | |
| Woodline Partners LP |
13F
|
Company |
2%
|
1,490,136
|
$53,838,614 | — | 31 Dec 2024 | |
| Siren, L.L.C. |
13F
|
Individual |
1.8%
|
1,377,701
|
$49,776,337 | — | 31 Dec 2024 | |
| Fiera Capital Corp |
13F
|
Company |
1.6%
|
1,219,189
|
$44,049,299 | — | 31 Dec 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
1.5%
|
1,103,858
|
$39,882,336 | — | 31 Dec 2024 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1.3%
|
974,385
|
$35,204,000 | — | 31 Dec 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.3%
|
971,099
|
$35,086,977 | — | 31 Dec 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
1.3%
|
945,808
|
$34,172,000 | — | 31 Dec 2024 | |
| Duquesne Family Office LLC |
13F
|
Company |
1.1%
|
859,694
|
$31,061,000 | — | 31 Dec 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
1.1%
|
796,684
|
$28,784,193 | — | 31 Dec 2024 | |
| Catalio Capital Management, LP |
13F
|
Company |
1%
|
764,668
|
$27,627,455 | — | 31 Dec 2024 | |
| Finepoint Capital LP |
13F
|
Company |
0.99%
|
748,752
|
$27,052,410 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.95%
|
717,714
|
$25,931,471 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.87%
|
655,678
|
$23,689,645 | — | 31 Dec 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.81%
|
614,923
|
$22,217,168 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.8%
|
605,248
|
$21,867,610 | — | 31 Dec 2024 | |
| SOROS FUND MANAGEMENT LLC |
13F
|
Company |
0.79%
|
600,470
|
$21,694,981 | — | 31 Dec 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.78%
|
592,645
|
$21,412,264 | — | 31 Dec 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.74%
|
557,067
|
$20,126,830 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.55%
|
416,888
|
$15,062,154 | — | 31 Dec 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.54%
|
407,683
|
$14,729,587 | — | 31 Dec 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.51%
|
387,733
|
$14,008,793 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.49%
|
373,231
|
$13,484,836 | — | 31 Dec 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.48%
|
364,060
|
$13,153,488 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.45%
|
339,917
|
$12,281,201 | — | 31 Dec 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.44%
|
328,911
|
$11,883,554 | — | 31 Dec 2024 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.39%
|
291,356
|
$10,526,691 | — | 31 Dec 2024 | |
| L. Mary Smith |
3/4/5
|
Chief Development Officer |
—
mixed-class rows
|
293,363
mixed-class rows
|
$9,691,565 | — | 04 Jan 2024 | |
| ORACLE INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.34%
|
254,773
|
$9,204,948 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.3%
|
227,935
|
$8,235,292 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.29%
|
222,178
|
$8,027,291 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.26%
|
195,942
|
$7,079,377 | — | 31 Dec 2024 |
Institutional Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) as of Q1 2025
As of 31 Mar 2025,
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) was held by
304 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
73,697,303 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, Woodline Partners LP, Polar Capital Holdings Plc, GEODE CAPITAL MANAGEMENT, LLC, Pictet Asset Management Holding SA, and D. E. Shaw & Co., Inc..
This page lists
305
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
214
Q1 2025 holders
304
Holder diff
90
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.